SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-143512

SYN-004

[SYN] Oscar Xenon · 64y · Male · Chinese · BMI 27.9 · ECOG 3
SMC - Sunway Medical Centre · Medical Oncology · Dr. Kavitha Sundaram
IVB (T4, N3, M1c)Partial Response
Not tested
Clinical storyline

[SYN] Oscar Xenon, a 64-year-old Chinese male (never, ECOG 3), presented in 2025-06 with fatigue and reduced appetite. Workup confirmed Adenocarcinoma (Stage IV). The MDT recommended platinum-based chemo-immunotherapy. Current status: Partial Response.

HPE Results
Adenocarcinoma: Acinar
Clinical Stage
IVB (T4, N3, M1c)
Pathological Stage
IVB (T4, N3, M1c)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
33.5
Tumor (CT/PET)
8.4 cm
PET SUV
11.55
NGS Results
No actionable driver mutations detected (52-gene panel)